GPT went back to its usual answers on the COVID-19 origin questions.

The strongest evidence is the convergence of early-case geography, market sampling, and viral phylogenetics around the Huanan Seafood Wholesale Market in Wuhan:

• •Earliest known cases clustered around the market. December 2019 cases—including many with no documented market contact—were geographically centered on it, suggesting the market was near the outbreak’s initial epicenter rather than merely a later superspreading site.
• •Live, SARS-CoV-2-susceptible mammals were sold there. Records and photographs document animals such as raccoon dogs, which can become infected and transmit the virus.
• •Environmental SARS-CoV-2 samples were concentrated near wildlife stalls. Positive swabs came from cages, carts, and surfaces in areas where live mammals were sold. Some samples contained both viral material and substantial raccoon-dog genetic material. This does not prove an animal was infected, because infected humans could have contaminated the same surfaces, but the spatial association is notable.
• •Early viral genomes appear to include two basal lineages, A and B. Several analyses conclude that this pattern is more consistent with at least two animal-to-human spillovers at the market than with a single introduction followed by human spread, although this inference depends on sparse early sampling and is debated.
• •SARS-CoV-2 fits within a naturally evolving bat-coronavirus lineage. Closely related sarbecoviruses have been found in horseshoe bats, and the genome does not contain generally accepted evidence of deliberate engineering.

The major limitation is that no infected market animal or immediate animal progenitor was identified: the market was closed and animals removed before they could be systematically tested. Thus, natural zoonotic transmission is supported most strongly by a coherent body of circumstantial evidence, not by a definitive “smoking gun.” A research-related origin has also not been conclusively ruled out, but publicly available evidence tying an ancestral virus or infected worker to a laboratory is comparatively limited.

There is no publicly available “smoking gun”—such as a laboratory record, stored precursor virus, infected employee sample, or accident report—showing that SARS‑CoV‑2 came from a lab. The strongest lab-incident case is therefore a combination of circumstantial facts:

• 1.Relevant coronavirus research was being done in Wuhan.
  The Wuhan Institute of Virology maintained a large collection of SARS-related bat coronaviruses and conducted virus isolation, cell-culture, animal, and genetic-engineering experiments. Some work was reportedly performed under biosafety conditions critics consider insufficient for novel respiratory viruses. This establishes opportunity, not origin.

• 2.The 2018 DEFUSE proposal.
  Researchers associated with the WIV proposed experiments involving SARS-related bat coronaviruses and the insertion or study of furin-cleavage sites. SARS‑CoV‑2 has a furin-cleavage site absent from its closest known relatives. DARPA rejected the proposal, however, and there is no public evidence that the proposed work was performed or that it produced SARS‑CoV‑2. Such sites can also evolve naturally.

• 3.The outbreak occurred in the same city as that research.
  Wuhan is far from the known habitats of the bats carrying the closest identified relatives of SARS‑CoV‑2. That coincidence raises a legitimate question, although Wuhan is also a major transport hub and wildlife-trading center. Early-case and environmental data strongly cluster around the Huanan market, supporting a competing animal-spillover explanation.

• 4.Incomplete disclosure and missing data.
  WIV virus databases became inaccessible before the outbreak, and China has not provided all laboratory records, staff health data, wildlife-supply records, or early patient samples sought by investigators. This prevents the lab hypothesis from being ruled out, but lack of transparency is not affirmative evidence of an accident.

• 5.No intermediate animal has been conclusively identified.
  No animal sampled from the market tested positive before it was cleared, although susceptible wildlife and SARS‑CoV‑2-positive environmental samples were found in the same areas. Failure to identify an infected source animal leaves uncertainty but does not itself point to a laboratory.

Reports that WIV employees became ill in autumn 2019 and various intelligence-agency assessments are often cited, but the public evidence behind them is limited or disputed. U.S. agencies have reached different conclusions, generally with low or moderate confidence.

Bottom line: The strongest lab-origin argument is the coincidence of location, relevant WIV research and capabilities, the DEFUSE proposal, and the absence of full records. None directly connects SARS‑CoV‑2 to a laboratory. The lab-incident hypothesis remains plausible but unproven; the natural-spillover hypothesis also remains viable and has substantial epidemiological support from the Huanan market evidence.